Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Epilepsy

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

Weight gain · people with drug‐resistant focal epilepsy

Pregabalin may leads to higher adverse effect: weight gain compared with placebo (low certainty).

1 finding from 1 review

Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
RR 4.35 [2.34, 8.11]
8 studies · 2488 participants
Low

Weight gain · people with drug‐resistant focal epilepsy

1 finding from 1 review

Pregabalin add‐on for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
2.87 [0.94, 8.75]
3 studies · 1286 participants
Low